NO913187L - Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.Info
- Publication number
- NO913187L NO913187L NO91913187A NO913187A NO913187L NO 913187 L NO913187 L NO 913187L NO 91913187 A NO91913187 A NO 91913187A NO 913187 A NO913187 A NO 913187A NO 913187 L NO913187 L NO 913187L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- therapeutic active
- tricyclic derivatives
- active tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909018044A GB9018044D0 (en) | 1990-08-16 | 1990-08-16 | Tricyclic heterocyclic derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO913187D0 NO913187D0 (no) | 1991-08-15 |
| NO913187L true NO913187L (no) | 1992-02-17 |
Family
ID=10680792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91913187A NO913187L (no) | 1990-08-16 | 1991-08-15 | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0471516A1 (fi) |
| JP (1) | JPH04257563A (fi) |
| KR (1) | KR920004352A (fi) |
| AU (1) | AU8142291A (fi) |
| CA (1) | CA2048298A1 (fi) |
| CS (1) | CS251091A3 (fi) |
| FI (1) | FI913893A (fi) |
| GB (2) | GB9018044D0 (fi) |
| HU (1) | HUT58293A (fi) |
| IE (1) | IE912616A1 (fi) |
| IL (1) | IL99075A0 (fi) |
| NO (1) | NO913187L (fi) |
| PT (1) | PT98680A (fi) |
| ZA (1) | ZA915937B (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997012872A1 (en) * | 1995-10-04 | 1997-04-10 | Eisai Co., Ltd. | Acridone compounds |
| US6063921A (en) * | 1997-11-20 | 2000-05-16 | Pharm-Eco Laboratories, Inc. | Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines |
| EP1351946A2 (en) | 2000-09-01 | 2003-10-15 | Icos Corporation | Materials and methods to potentiate cancer treatment |
| AU2004223866A1 (en) | 2003-03-24 | 2004-10-07 | Luitpold Pharmaceuticals, Inc. | Xanthones, thioxanthones and acridinones as DNA-PK inhibitors |
| PL2130817T3 (pl) * | 2008-06-05 | 2016-06-30 | Agfa Graphics Nv | Polimeryzowalne fotoinicjatory typu ii oraz kompozycje utwardzalne |
| US11866412B1 (en) | 2023-03-03 | 2024-01-09 | King Faisal University | Acridin-9-one compounds as antibacterial agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH498841A (fr) * | 1967-07-13 | 1970-11-15 | Inst Farmaceutyczny | Procédé de préparation de benzo-(b,1,8)-naphtyridones-5 substituées |
| DE2759468A1 (de) * | 1977-08-29 | 1979-06-07 | Sterling Drug Inc | Acridinonverbindungen und ihre herstellung |
-
1990
- 1990-08-16 GB GB909018044A patent/GB9018044D0/en active Pending
-
1991
- 1991-07-24 IE IE261691A patent/IE912616A1/en unknown
- 1991-07-26 HU HU912511A patent/HUT58293A/hu unknown
- 1991-07-29 AU AU81422/91A patent/AU8142291A/en not_active Abandoned
- 1991-07-29 ZA ZA915937A patent/ZA915937B/xx unknown
- 1991-08-01 CA CA002048298A patent/CA2048298A1/en not_active Abandoned
- 1991-08-02 GB GB919116779A patent/GB9116779D0/en active Pending
- 1991-08-04 IL IL99075A patent/IL99075A0/xx unknown
- 1991-08-09 EP EP91307341A patent/EP0471516A1/en not_active Withdrawn
- 1991-08-14 PT PT98680A patent/PT98680A/pt not_active Application Discontinuation
- 1991-08-14 KR KR1019910014211A patent/KR920004352A/ko not_active Application Discontinuation
- 1991-08-14 CS CS912510A patent/CS251091A3/cs unknown
- 1991-08-15 NO NO91913187A patent/NO913187L/no unknown
- 1991-08-15 JP JP3205027A patent/JPH04257563A/ja active Pending
- 1991-08-16 FI FI913893A patent/FI913893A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL99075A0 (en) | 1992-07-15 |
| PT98680A (pt) | 1992-08-31 |
| HUT58293A (en) | 1992-02-28 |
| JPH04257563A (ja) | 1992-09-11 |
| GB9116779D0 (en) | 1991-09-18 |
| KR920004352A (ko) | 1992-03-27 |
| GB9018044D0 (en) | 1990-10-03 |
| EP0471516A1 (en) | 1992-02-19 |
| IE912616A1 (en) | 1992-02-26 |
| FI913893A (fi) | 1992-02-17 |
| NO913187D0 (no) | 1991-08-15 |
| FI913893A0 (fi) | 1991-08-16 |
| HU912511D0 (en) | 1992-01-28 |
| CA2048298A1 (en) | 1992-02-17 |
| CS251091A3 (en) | 1992-03-18 |
| AU8142291A (en) | 1992-02-20 |
| ZA915937B (en) | 1992-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO904694L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO903088D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
| NO914667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater | |
| NO894630D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO905201D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzofuran-derivater. | |
| NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO893616L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser. | |
| NO904986D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
| NO910395L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater. | |
| NO910935D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater. | |
| NO884174D0 (no) | Framgangsmaate for fremstilling av terapeutisk aktive tricykliske amidinoderivater. | |
| NO881762D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater. | |
| NO900697D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater. | |
| NO891723D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO895220L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater. | |
| NO913187D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. | |
| NO905327L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater. | |
| NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO890724D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
| NO904470D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater. | |
| NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. | |
| NO880492D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske triazolpyrimidinderivater. | |
| NO900812D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive laktamderivater. |